Information till studenter och medarbetare med anledning av covid-19 (Uppdaterad: 20 januari 2021)

English
Umeå universitet
printicon
Personalbild Oskar Hemmingsson

Oskar Hemmingsson

Biträdande universitetslektor och överläkare med inriktning mot övre abdominell kirurgi. Driver klinisk och translationell cancerforskning och undervisar på läkarprogrammet.

Kontakt

E-post
oskar.hemmingsson@umu.se
Telefon
090-785 85 45, 070-719 75 48

Verksam vid

Anknytning
Universitetslektor, överläkare vid Institutionen för kirurgisk och perioperativ vetenskap Enhet: Kirurgi
Plats
1A 9 tr, Kirurgcentrum Kirurgcentrum, Norrlands universitetssjukhus, 901 85 Umeå
Anknytning
Anknuten som övrig/annan befattning till Wallenberg centrum för molekylär medicin vid Umeå universitet (WCMM)
Plats
Umeå universitet, 901 87 Umeå
2020
Treatment patterns and survival in patients with hepatocellular carcinoma in the Swedish national registry SweLiv
BJS Open, John Wiley & Sons 2020, Vol. 4, (1) : 109-117
Henriksson, M.; Bjornsson, B.; Sternby Eilard, M.; et al.
2020
Regional variations in the treatment of gallstone disease may affect patient outcome: A large, population-based register study in sweden
Scandinavian Journal of Surgery
Lindqvist, Lisa; Sandblom, G.; Nordin, Pär; et al.
2020
Quality-of-life after bile duct injury repaired by hepaticojejunostomy: a national cohort study
Scandinavian Journal of Gastroenterology, Taylor & Francis 2020, Vol. 55, (9) : 1087-1092
Sturesson, Christian; Hemmingsson, Oskar; Mansson, Christopher; et al.
2020
Surgical treatment of breast cancer liver metastases: A nationwide registry-based case control study
European Journal of Surgical Oncology, Elsevier 2020, Vol. 46, (6) : 1006-1012
Sundén, Marcus; Hermansson, Cecilia; Taflin, Helena; et al.
2019
Association between physical activity and risk of hepatobiliary cancers: A multinational cohort study
Journal of Hepatology, Vol. 70, (5) : 885-892
Baumeister, Sebastian E.; Schlesinger, Sabrina; Aleksandrova, Krasimira; et al.
2019
Circulating insulin-like growth factor I in relation to melanoma risk in the European prospective investigation into cancer and nutrition
International Journal of Cancer, John Wiley & Sons 2019, Vol. 144, (5) : 957-966
Bradbury, Kathryn E.; Appleby, Paul N.; Tipper, Sarah J.; et al.
2019
Post cholecystectomy bile duct injury: early, intermediate or late repair with hepaticojejunostomy - an E-AHPBA multi-center study
HPB, Elsevier 2019, Vol. 21, (12) : 1641-1647
Rystedt, Jenny M. L.; Kleeff, Joerg; Salvia, Roberto; et al.
2017
Coffee, tea and melanoma risk: findings from the European Prospective Investigation into Cancer and Nutrition
International Journal of Cancer, Vol. 140, (10) : 2246-2255
Caini, Saverio; Masala, Giovanna; Saieva, Calogero; et al.
2017
Exposure to bacterial products lipopolysaccharide and flagellin and hepatocellular carcinoma: a nested case-control study
BMC Medicine, BioMed Central 2017, Vol. 72, (15)
Fedirko, Veronika; Tran, Hao Quang; Gewirtz, Andrew T; et al.
2016
Circulating Osteopontin and Prediction of Hepatocellular Carcinoma Development in a Large European Population
Cancer Prevention Research, Vol. 9, (9) : 758-765
Duarte-Salles, Talita; Misra, Sandeep; Stepien, Magdalena; et al.
2016
Prediagnostic selenium status and hepatobiliary cancer risk in the European Prospective Investigation into Cancer and Nutrition cohort
American Journal of Clinical Nutrition, Vol. 104, (2) : 406-414
Hughes, David J.; Duarte-Salles, Talita; Hybsier, Sandra; et al.
2016
Anterior Resection for Rectal Cancer and Visceral Blood Flow: An Explorative Study
Scandinavian Journal of Surgery, Vol. 105, (2) : 78-83
Rutegård, Martin; Hassmén, N; Hemmingsson, Oskar; et al.
2014
eIF4F is a nexus of resistance to anti-BRAF and anti-MEK cancer therapies
Nature, Vol. 513, (7516) : 105-109
Boussemart, Lise; Malka-Mahieu, Hélène; Girault, Isabelle; et al.
2013
Depletion of the ER chaperone ENPL-1 sensitizes C. elegans to the anticancer drug cisplatin
Worm, Landes Bioscience 2013, Vol. 2, (1)
Natarajan, Balasubramanian; Gaur, Rahul; Hemmingsson, Oskar; et al.
2012
High tie in anterior resection for rectal cancer confers no increased risk of anastomotic leakage
British Journal of Surgery, Malden, MA: Wiley-Blackwell 2012, Vol. 99, (1) : 127-132
Rutegård, Martin; Hemmingsson, Oskar; Matthiessen, P.; et al.
2010
ASNA1 and cisplatin resistance: studies in C. elegans and in human tumor cells
Umeå University medical dissertations, 1390
Hemmingsson, Oskar
2010
ASNA-1 activity modulates sensitivity to cisplatin
Cancer Research, American Association for Cancer Research 2010, Vol. 70, (24) : 10321-10328
Hemmingsson, Oskar; Kao, Gautam; Still, Maria; et al.
2009
Increased sensitivity to platinating agents and arsenite in human ovarian cancer by downregulation of ASNA1
Oncology Reports, Spandidos Publications 2009, Vol. 22, (4) : 869-875
Hemmingsson, Oskar; Nöjd, Mikael; Kao, Gautam; et al.
2009
ASNA1, an ATPase targeting tail-anchored proteins, regulates melanoma cell growth and sensitivity to cisplatin and arsenite
Cancer Chemotherapy and Pharmacology, Springer 2009, Vol. 63, (3) : 491-499
Hemmingsson, Oskar; Zhang, Youyi; Still, Maria; et al.
­ASNA-1 influence on apoptosis in C. elegans
Kao, Gautam; Hemmingsson, Oskar; Chitturi, Jyothsna; et al.
Unfolded protein response and enpl-1 depletion sensitize C. elegans to the anti-cancer drug cisplatin
Natarajan, Balasubramanian; Hemmingsson, Oskar; Kao, Gautam; et al.
Visa publikationer i DiVA

Forskningsprojekt

1 januari 2020 till 31 december 2029
The BRECLIM trial
1 januari 2013
Cancerforskning (PI Hemmingsson)
Masken C Elegans – en elegant cancermodell?
Masken C Elegans – en elegant cancermodell?

Oskar Hemmingsson föreläste om hur masken C Elegans kan användas som en elegant cancermodell i forskningen.